Akebia Therapeutics (AKBA) News Today $3.60 -0.03 (-0.69%) Closing price 07/3/2025 02:45 PM EasternExtended Trading$3.62 +0.01 (+0.28%) As of 07/3/2025 04:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AKBA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Akebia Therapeutics, Inc. (AKBA) - Yahoo Finance1 hour ago | finance.yahoo.comAkebia Therapeutics, Inc. (AKBA) Shareholders Greenlight 18.9 Million Share IncreaseJuly 2 at 11:41 PM | insidermonkey.comAkebia Therapeutics, Inc. (AKBA) Shareholders Greenlight 18.9 Million Share IncreaseJuly 2 at 11:02 PM | msn.comErik Ostrowski Sells 41,314 Shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) StockJuly 2 at 5:41 AM | insidertrades.comAkebia Therapeutics, Inc. (NASDAQ:AKBA) CFO Sells $151,622.38 in StockJuly 1 at 6:07 PM | marketbeat.comAkebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 1 at 4:05 PM | globenewswire.comAkebia Therapeutics Reports Positive Results from its Vadadustat Global Phase 3 Clinical TrialsJuly 1 at 5:22 AM | msn.comAkebia Therapeutics (AKBA) Grants Stock Options to New EmployeesJune 29, 2025 | msn.comAkebia Therapeutics, Inc. (NASDAQ:AKBA) Receives $6.75 Average Target Price from AnalystsJune 24, 2025 | americanbankingnews.comAkebia Therapeutics, Inc. (NASDAQ:AKBA) Given Average Rating of "Buy" by BrokeragesJune 19, 2025 | marketbeat.comAkebia Therapeutics (NASDAQ:AKBA) Trading Up 2.8% - Here's What HappenedJune 12, 2025 | marketbeat.comRichard C. Malabre Sells 15,000 Shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) StockJune 12, 2025 | insidertrades.comAkebia Therapeutics, Inc. (NASDAQ:AKBA) CAO Richard C. Malabre Sells 15,000 SharesJune 11, 2025 | marketbeat.comAkebia Therapeutics (NASDAQ:AKBA) Stock Price Down 3.7% - Should You Sell?June 11, 2025 | marketbeat.comMillennium Management LLC Boosts Stock Holdings in Akebia Therapeutics, Inc. (NASDAQ:AKBA)June 11, 2025 | marketbeat.comAkebia Therapeutics (NASDAQ:AKBA) Sees Unusually-High Trading Volume - Should You Buy?June 10, 2025 | marketbeat.comAkebia Therapeutics (NASDAQ:AKBA) Reaches New 1-Year High - Should You Buy?June 9, 2025 | marketbeat.comAkebia Therapeutics: Stock Is Trading At Fair Value Amid Robust Drug Adoption Into 2026June 8, 2025 | seekingalpha.comWellington Management Group LLP Acquires 97,409 Shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA)June 7, 2025 | marketbeat.comBank of America Corp DE Purchases 294,343 Shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA)June 7, 2025 | marketbeat.comInsider Selling: Akebia Therapeutics, Inc. (NASDAQ:AKBA) CAO Sells 13,334 Shares of StockJune 6, 2025 | insidertrades.comQ2 Earnings Forecast for AKBA Issued By HC WainwrightJune 6, 2025 | marketbeat.comMackenzie Financial Corp Has $257,000 Stock Holdings in Akebia Therapeutics, Inc. (NASDAQ:AKBA)June 6, 2025 | marketbeat.comH.C. Wainwright Initiates Coverage of Akebia Therapeutics (AKBA) With Buy RatingJune 5, 2025 | msn.comRichard C. Malabre Sells 13,334 Shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) StockJune 5, 2025 | marketbeat.comAkebia Therapeutics: Finally Showing Potential, But Wait For Q2 Earnings Before BuyingJune 4, 2025 | seekingalpha.comAkebia Therapeutics (NASDAQ:AKBA) Stock Price Up 4.8% - What's Next?June 4, 2025 | marketbeat.comAkebia Therapeutics (NASDAQ:AKBA) Earns Buy Rating from HC WainwrightJune 4, 2025 | marketbeat.comVadadustat U.S. Patient Data from Global Phase 3 Clinical Program Published in Journal of the American Society of NephrologyJune 4, 2025 | globenewswire.comAkebia Therapeutics (NASDAQ:AKBA) Reaches New 52-Week High - Here's WhyJune 3, 2025 | marketbeat.comAkebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 2, 2025 | globenewswire.comAkebia Therapeutics (NASDAQ:AKBA) Stock Price Up 6.8% - Should You Buy?May 30, 2025 | marketbeat.comAkebia Therapeutics (NASDAQ:AKBA) Reaches New 12-Month High - What's Next?May 29, 2025 | marketbeat.comAkebia Therapeutics to Present at the Jefferies Global Healthcare Conference 2025May 28, 2025 | globenewswire.comAkebia Therapeutics Announces Three Poster Presentations at the European Renal Association Congress 2025May 27, 2025 | globenewswire.comRafferty Asset Management LLC Makes New $342,000 Investment in Akebia Therapeutics, Inc. (NASDAQ:AKBA)May 26, 2025 | marketbeat.comAkebia Therapeutics, Inc. (NASDAQ:AKBA) Given Consensus Recommendation of "Buy" by BrokeragesMay 26, 2025 | marketbeat.comAkebia Therapeutics at H.C. Wainwright Conference: Vafseo’s Strategic LaunchMay 22, 2025 | investing.com125,680 Shares in Akebia Therapeutics, Inc. (NASDAQ:AKBA) Acquired by Dimensional Fund Advisors LPMay 20, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Sells 805,459 Shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA)May 18, 2025 | marketbeat.comBalyasny Asset Management L.P. Purchases Shares of 274,452 Akebia Therapeutics, Inc. (NASDAQ:AKBA)May 18, 2025 | marketbeat.comAkebia Therapeutics (NASDAQ:AKBA) Trading Down 6.5% - Here's WhyMay 14, 2025 | marketbeat.comAkebia Therapeutics to Present at the H.C. Wainwright 3rd Annual BioConnect Investor ConferenceMay 13, 2025 | finance.yahoo.comAkebia Therapeutics to Present at the H.C. Wainwright 3rd Annual BioConnect Investor ConferenceMay 13, 2025 | globenewswire.comAkebia Therapeutics, Inc. (NASDAQ:AKBA) Shares Purchased by Barclays PLCMay 10, 2025 | marketbeat.comEarnings call transcript: Akebia Therapeutics beats Q1 2025 estimates, stock surgesMay 9, 2025 | uk.investing.comAkebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2025 Earnings Call TranscriptMay 9, 2025 | msn.comAkebia Therapeutics Inc (AKBA) Q1 2025 Earnings Call Highlights: Strong Revenue Performance and ...May 9, 2025 | finance.yahoo.comAkebia Therapeutics Reports First Quarter 2025 Financial Results and Recent Business HighlightsMay 8, 2025 | finance.yahoo.comAkebia Therapeutics, Inc. (AKBA) Q1 2025 Earnings Call TranscriptMay 8, 2025 | seekingalpha.com Get Akebia Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AKBA and its competitors with MarketBeat's FREE daily newsletter. Email Address AKBA Media Mentions By Week AKBA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AKBA News Sentiment▼0.710.54▲Average Medical News Sentiment AKBA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AKBA Articles This Week▼84▲AKBA Articles Average Week Get Akebia Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AKBA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MRUS News ACLX News ACAD News SWTX News RARE News AAPG News PTGX News RNA News SRRK News MLTX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AKBA) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akebia Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akebia Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
